Kezar Life Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -227 | -251 | |
EBITDA | -11,000 | -13,159 | -15,958 |
EBIT | -11,227 | -13,402 | -16,209 |
Net Income | -11,227 | -13,704 | -16,556 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -9,830 | -12,795 | -17,198 |
Cash | 38,935 | 34,367 | 37,002 |
Basic Shares | 7,323 | 7,311 | 7,305 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $7,000 | $0 |
Gross Profit | -1,040 | 7,000 | -1,022 |
EBITDA | -81,103 | -99,254 | -70,139 |
EBIT | -82,143 | -100,320 | -71,162 |
Net Income | -83,736 | -101,870 | -65,316 |
Net Change In Cash | 0 | 7,000 | 0 |
Cost of Revenue | -22,377 | ||
Free Cash Flow | -74,241 | -83,455 | -60,424 |
Cash | 41,749 | 35,493 | 40,456 |
Basic Shares | 72,902 | 72,553 | 67,368 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.05 |
2025-09-30 | -$1.53 |
2025-06-30 | -$1.87 |
2025-03-31 | -$2 |
